Venous Leg Ulcer Treatment Market
The venous leg ulcer treatment market is gaining momentum due to the rising prevalence of chronic venous insufficiency (CVI) and the global aging population. Venous leg ulcers (VLUs) are slow-healing wounds caused by poor blood flow in the lower limbs. Effective treatment requires a combination of compression therapy, wound management, and, increasingly, advanced biologics.
Market Overview
Chronic wounds, particularly VLUs, impose a major healthcare burden, affecting millions of patients worldwide. With rising incidences of obesity, diabetes, and vascular disorders, the demand for effective therapies continues to increase. The market is evolving toward advanced wound care technologies, emphasizing faster healing and lower recurrence.
Key Growth Drivers
Increasing Geriatric PopulationOlder adults are more prone to venous disorders, driving demand for long-term wound management solutions.